Anne Cornelissen

2.6k total citations · 1 hit paper
58 papers, 1.6k citations indexed

About

Anne Cornelissen is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anne Cornelissen has authored 58 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Surgery, 18 papers in Cardiology and Cardiovascular Medicine and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anne Cornelissen's work include Coronary Interventions and Diagnostics (35 papers), Peripheral Artery Disease Management (12 papers) and Antiplatelet Therapy and Cardiovascular Diseases (8 papers). Anne Cornelissen is often cited by papers focused on Coronary Interventions and Diagnostics (35 papers), Peripheral Artery Disease Management (12 papers) and Antiplatelet Therapy and Cardiovascular Diseases (8 papers). Anne Cornelissen collaborates with scholars based in United States, Germany and Italy. Anne Cornelissen's co-authors include Aloke V. Finn, Atsushi Sakamoto, Renu Virmani, Liang Guo, Yu Sato, Maria Romero, Frank D. Kolodgie, Hiroyuki Jinnouchi, Masayuki Mori and Rika Kawakami and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Anne Cornelissen

55 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Microthrombi as a Major Cause of Cardiac Injury in COVID-19

2021 173 citations Dario Pellegrini, Rika Kawakami et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne Cornelissen United States	17	565	472	306	304	275	58	1.6k
Maria Romero United States	22	730 1.3×	755 1.6×	246 0.8×	500 1.6×	274 1.0×	62	1.9k
Alberto Polimeni Italy	25	687 1.2×	942 2.0×	462 1.5×	299 1.0×	67 0.2×	92	1.8k
Zhizhong Liu China	21	653 1.2×	344 0.7×	345 1.1×	193 0.6×	92 0.3×	85	1.5k
Haodong Xu United States	21	441 0.8×	126 0.3×	580 1.9×	425 1.4×	490 1.8×	60	1.9k
Rima Dardik Israel	29	285 0.5×	367 0.8×	449 1.5×	515 1.7×	65 0.2×	95	2.4k
Deborah Vela United States	22	1.1k 1.9×	606 1.3×	704 2.3×	236 0.8×	63 0.2×	68	2.5k
Kentaro Jujo Japan	21	592 1.0×	513 1.1×	552 1.8×	312 1.0×	41 0.1×	90	1.8k
Sho Torii Japan	26	1.5k 2.7×	896 1.9×	214 0.7×	853 2.8×	74 0.3×	111	2.5k
Ruth S. Waterman United States	17	761 1.3×	220 0.5×	461 1.5×	328 1.1×	43 0.2×	43	2.2k
Niklas Bergh Sweden	19	409 0.7×	237 0.5×	200 0.7×	249 0.8×	55 0.2×	74	1.1k

Countries citing papers authored by Anne Cornelissen

Since Specialization

Citations

This map shows the geographic impact of Anne Cornelissen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Cornelissen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Cornelissen more than expected).

Fields of papers citing papers by Anne Cornelissen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Cornelissen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Cornelissen. The network helps show where Anne Cornelissen may publish in the future.

Co-authorship network of co-authors of Anne Cornelissen

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Cornelissen. A scholar is included among the top collaborators of Anne Cornelissen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Cornelissen. Anne Cornelissen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cornelissen, Anne, Stefanie Reese, Marek Behr, et al.. (2023). In-vivo assessment of vascular injury for the prediction of in-stent restenosis. International Journal of Cardiology. 388. 131151–131151. 5 indexed citations

Cornelissen, Anne, et al.. (2022). Fibroblast Growth Factor 23 and Outcome Prediction in Patients with Acute Myocardial Infarction. Journal of Clinical Medicine. 11(3). 601–601. 5 indexed citations

Liehn, Elisa A., Jörg Schröder, Mohammad Almalla, et al.. (2022). Dose-dependent impact of statin therapy intensity on circulating progenitor cells in patients undergoing percutaneous coronary intervention for the treatment of acute versus chronic coronary syndrome. PLoS ONE. 17(5). e0267433–e0267433. 1 indexed citations

Pellegrini, Dario, Rika Kawakami, Giulio Guagliumi, et al.. (2021). Microthrombi as a Major Cause of Cardiac Injury in COVID-19. Circulation. 143(10). 1031–1042. 173 indexed citations breakdown →

Cornelissen, Anne, Liang Guo, Raquel Fernandez, et al.. (2021). Endothelial Recovery in Bare Metal Stents and Drug-Eluting Stents on a Single-Cell Level. Arteriosclerosis Thrombosis and Vascular Biology. 41(8). 2277–2292. 10 indexed citations

Mori, Masayuki, Atsushi Sakamoto, Yu Sato, et al.. (2021). Overcoming challenges in refining the current generation of coronary stents. Expert Review of Cardiovascular Therapy. 19(11). 1013–1028. 2 indexed citations

Cornelissen, Anne, Matthew Kutyna, Qi Cheng, et al.. (2021). Effects of Simulated COVID-19 Cytokine Storm on Stent Thrombogenicity. Cardiovascular revascularization medicine. 35. 129–138. 7 indexed citations

Kawakami, Rika, Atsushi Sakamoto, Kenji Kawai, et al.. (2021). Pathological Evidence for SARS-CoV-2 as a Cause of Myocarditis. Journal of the American College of Cardiology. 77(3). 314–325. 150 indexed citations

Sato, Yu, Hiroyuki Jinnouchi, Frank D. Kolodgie, et al.. (2021). Acute thrombogenicity of fluoropolymer coated stents versus competitive drug-eluting stents under single antiplatelet therapy. International Journal of Cardiology. 338. 42–49. 6 indexed citations

10.

Sato, Yu, Rika Kawakami, Atsushi Sakamoto, et al.. (2021). Efficacy and safety of cerebral embolic protection systems during transcatheter aortic valve replacement: a review of current clinical findings. Expert Review of Cardiovascular Therapy. 19(8). 725–737. 5 indexed citations

11.

Sakamoto, Atsushi, Rika Kawakami, Kenji Kawai, et al.. (2020). ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Serine Protease 2) Expression and Localization of SARS-CoV-2 Infection in the Human Heart. Arteriosclerosis Thrombosis and Vascular Biology. 41(1). 542–544. 33 indexed citations

12.

Sato, Yu, Rika Kawakami, Hiroyuki Jinnouchi, et al.. (2020). TCT CONNECT-138 Histologic Calcification is Uncommon After Self-Expanding Transcatheter Bioprosthesis Implantation Through 5 Years. Journal of the American College of Cardiology. 76(17). B60–B60.

13.

Kuntz, Salomé, Hiroyuki Jinnouchi, Matthew Kutyna, et al.. (2020). Co-Registration of Peripheral Atherosclerotic Plaques Assessed by Conventional CT Angiography, MicroCT and Histology in Patients with Chronic Limb Threatening Ischaemia. European Journal of Vascular and Endovascular Surgery. 61(1). 146–154. 9 indexed citations

14.

Sato, Yu, Hiroyuki Jinnouchi, Frank D. Kolodgie, et al.. (2020). TCT CONNECT-250 Comparison of Thromboresistance of Everolimus-Eluting Fluoropolymer Stents and Competitive Drug-Eluting Stents Between Aspirin and Clopidogrel Single Antiplatelet Therapy Using an Ex Vivo Swine Shunt Model and Evaluation of a Novel Flow Loop Model Under Aspirin Single Antiplatelet Therapy. Journal of the American College of Cardiology. 76(17). B110–B111. 1 indexed citations

15.

Sakamoto, Atsushi, Sho Torii, Hiroyuki Jinnouchi, et al.. (2020). Comparison of Endothelial Barrier Functional Recovery After Implantation of a Novel Biodegradable-Polymer Sirolimus-Eluting Stent in Comparison to Durable- and Biodegradable-Polymer Everolimus-Eluting Stents. Cardiovascular revascularization medicine. 24. 1–10. 7 indexed citations

16.

Sato, Yu, Hiroyuki Jinnouchi, Atsushi Sakamoto, et al.. (2020). Calcification in human vessels and valves: from pathological point of view. SHILAP Revista de lepidopterología. 7(3). 183–210. 6 indexed citations

17.

Jain, Manish, Nirav Dhanesha, Prakash Doddapattar, et al.. (2019). Smooth muscle cell–specific fibronectin-EDA mediates phenotypic switching and neointimal hyperplasia. Journal of Clinical Investigation. 130(1). 295–314. 59 indexed citations

18.

Jinnouchi, Hiroyuki, Frank D. Kolodgie, Qi Cheng, et al.. (2019). TCT-291 Comparison of Thromboresistance Between Everolimus-Eluting Fluoropolymer Stent and Currently Available Drug-Eluting Stent in an Ex Vivo Swine Shunt Model Under Only Single Antiplatelet Therapy. Journal of the American College of Cardiology. 74(13). B290–B290. 1 indexed citations

19.

Cornelissen, Anne, Sakine Simsekyilmaz, Elisa A. Liehn, et al.. (2019). Apolipoprotein E deficient rats generated via zinc-finger nucleases exhibit pronounced in-stent restenosis. Scientific Reports. 9(1). 18153–18153. 12 indexed citations

20.

Flanagan, Thomas C., Anne Cornelissen, Sabine Koch, et al.. (2008). Development of a Composite Degradable/Nondegradable Tissue‐engineered Vascular Graft. Artificial Organs. 32(10). 800–809. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact